Page 7 - UHN-RR2020-6_Neat

All Hands on Deck

Researchers across disciplines step up to advance COVID-19 research

PROTECT Drs. Steven Chan (pictured) and
Vikas Gupta are leading a clinical study to
determine whether an established blood cancer
drug, known as ruxolitinib, can safely reduce
the need for ventilation in patients with severe
COVID-19. > read more

PREVENT Drs. Ewan Goligher and Patrick
Lawler (pictured) are leading an international
clinical trial to determine if heparin, a drug used
to prevent blood clots, improves outcomes for
COVID-19 patients at high risk of developing blood
clots in the lungs. > read more

OBSERVE In a preliminary case series, Drs.
Patrick Nicholson, Laila Alshafai and Timo
Krings observed evidence of internal bleeding
and clotting in the blood vessels of the brain of
individuals with severe COVID-19. > read more

SHIELD Laboratories at UHN have partnered
with medical programs to design, manufacture
and test medical-grade personal protective
equipment. These initiatives are supporting
frontline workers by providing them with a
reliable supply of protective equipment, including
3D-printed face shields, patient-monitoring
components and alternatives to disposable N95
masks. > read more

5